Pharmaceutical

Filter

Current filters:

None

Popular Filters

6776 to 6800 of 7202 results

Lonza and Agennix link up for talactoferrin production

12-04-2012

Switzerland-based Lonza (SIX: LONN) and Agennix AG (FSE: AGX) of Germany have announced an agreement…

AgennixBiotechnologyLonzaOncologyPharmaceuticalResearchtalactoferrin

Pharma giants set to lose dominance in urological disorders market

12-04-2012

Major pharmaceutical companies are predicted to lose their footing in the urological disorders market…

Genito-urinaryMarkets & MarketingPatentsPharmaceutical

No case for further cuts to Australian PBS, conference told

12-04-2012

The biggest round of price cuts in the history of the Australian Pharmaceutical Benefits Scheme, coupled…

Asia-PacificPharmaceuticalPricing

EFPIA debuts tendering process for Medicines Verification System

12-04-2012

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the official…

EuropeMarkets & MarketingPharmaceuticalRegulation

Drugs may ease depression without worsening motor problems for PD patients

12-04-2012

Certain antidepressants appear to decrease depression in people with Parkinson's disease without worsening…

Effexor XRGlaxoSmithKlineNeurologicalparoxetinePaxilPfizerPharmaceuticalResearchvenlafaxine

Takeda to acquire URL Pharma for $800 million

12-04-2012

Japanese drug major Takeda Pharmaceutical (TYO: 4502) said yesterday that it has reached agreement to…

ColcrysMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalsUloricURL Pharma

Roche 1st-qtr sales up 2%, on track for full year targets

12-04-2012

Swiss drug major Roche (ROG: SIX) says it is on track to achieve 2012 sales targets, posting first quarter…

FinancialPharmaceuticalRoche

Abbott's Humira OKed for new ulcerative colitis indication in EU

12-04-2012

Following a previous favorable advisory committee recommendation, US health care major Abbott Laboratories…

Abbott LaboratoriesEuropeGastro-intestinalsHumiraInflammatory diseasesPharmaceuticalRegulation

Arrowhead takes over Alvos Thera in stock deal

12-04-2012

USA-based nano-medicine developer Arrowhead Research Corp (Nasdaq: ARWR) says it has acquired Alvos Therapeutics…

Alvos TherapeuticsArrowhead ResearchBiotechnologyMergers & AcquisitionsPharmaceutical

News briefs on Janssen, Bayer and Merck KGaA/Threshold

12-04-2012

In the USA, the Arkansas jury found that the Janssen unit of US health care giant Johnson & Johnson (NYSE:…

BayerFinancialJanssenJohnson & JohnsonLegalMerck KGaAPharmaceuticalRegulationRisperdalThreshold PharmaceuticalsXarelto

Menarini extends febuxostat accord to more regions

12-04-2012

Japanese drugmaker Teijin Pharma and privately-owned Italian pharmaceutical company Menarini have signed…

febuxostatGenito-urinaryLicensingMenariniPharmaceuticalTeijin

SHA to fund Roche breast cancer drug Avastin in London

12-04-2012

Women with aggressive metastatic breast cancer in the UK capital London now have access to a drug which…

AvastinOncologyPharmaceuticalPricingRegulationRoche

European regulators see way forward for publication of full clinical trial data

12-04-2012

A group of European regulators have set out a way forward for the publication of the results of clinical…

EuropePharmaceuticalRegulationResearch

Risks and benefits of the first line treatment for diabetes with metformin

11-04-2012

Although the drug metformin is considered the gold standard in the management of type 2 diabetes, a study…

DiabetesmetforminPharmaceuticalResearch

Drugs registration project launched in East Africa

11-04-2012

A Medicines Registration Harmonization project to address issues related to improving supplies and harmonize…

GenericsPharmaceuticalRegulationRest of the World

US contract manufacturing outsourcing market revives, says F&S

11-04-2012

The upturn in the fortunes of pharmaceutical companies after the recession is mirrored by the US contract…

Markets & MarketingNorth AmericaPharmaceutical

Bayer updates drospirenone-containing COCs labels to reflect VTE risk

11-04-2012

Following a further review of the products by the US Food and Drug Administration , Bayer HealthCare…

BayerBeyazdrospirenoneNorth AmericaPharmaceuticalRegulationReproductiveWomen's HealthYasminYaz

Germany's IQWiG finds some benefit for Pfizer orphan drug Vyndaqel

11-04-2012

The German Institute for Quality and Efficiency in Health Care (IQWiG) has assessed Vyndaqel (tafamidis),…

EuropePfizerPharmaceuticalPricingRare diseasesRegulationVyndaqel

Vivus says FDA has delayed Qnexa PDUFA date

10-04-2012

The US Food and Drug Administration has advised informed USA-based rug developer Vivus (Nasdaq: VVUS)…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

GlaxoSmithKline links with Japan's Chiome on MAbs

10-04-2012

UK pharma giant GlaxoSmithKline group (LSE: GSK) and Tokyo, Japan-based biotech-venture company Chiome…

BiotechnologyChiome BioscienceGlaxoSmithKlineImmunologicalsLicensingOncologyPharmaceuticalResearch

Recommendations on universal health care coverage in India

10-04-2012

India Health Progress has released the analysis presented by Dileep Malvankar, Dean of Public Health,…

Asia-PacificFinancialGenericsHealthcarePharmaceuticalPricing

Incivek versus Victrelis in hepatitis C virus treatment: US physician views

10-04-2012

For the treatment of hepatitis C virus (HCV), the majority of surveyed US physicians survey by advisory…

Anti-viralsIncivekMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalRocheVertexVictrelis

6776 to 6800 of 7202 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top